The Challenge for OTC Issuers
OTC alternative reporting companies often face the toughest path to accessing capital. Without audited financials or SEC reporting status, traditional financing avenues are limited, and institutional participation is often out of reach.
RH2 Equity Partners focuses on structuring compliant, issuer-aligned capital solutions for OTC Pink and OTCQB companies. Our approach combines structured financings, debt restructuring, and strategic capital planning to create executable pathways to funding while maintaining alignment with applicable regulatory frameworks.
Our 3 Core Funding Programs
Each program targets a distinct financing challenge faced by OTC issuers. Together, they form a flexible toolkit for growth, recapitalization, and investor confidence.
Why OTC Issuers Choose RH2 + Pinnacle
Audit-Free Pathways: Access meaningful capital even if your financials are unaudited.
No Upfront Costs: Legal, accounting, and filing expenses are covered as part of the raise.
Market-Maker & Aftermarket Support: Built-in liquidity assistance post-funding.
Compliant & Transparent: Every structure is fully SEC-compliant, OTC-friendly, and issuer-protective.
Aligned Incentives: We succeed only when your capital raise succeeds.